Demetris Epaminondas

Mr. Demetris Epaminondas

orcid
DVM, MVSc, MPA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Nature
Verified
Journal Article
Open access
PDF file
CACharalampos Attipa
Charalampos Attipa
AWAmanda S. Warr
Amanda S. Warr
DEDemetris Epaminondas
Demetris Epaminondas
MOMarie O’sHea
Marie O’sHea
AHAndrew J. Hanton
Andrew J. Hanton
CTChristine Tait-Burkard
Christine Tait-Burkard
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health1–3. While the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed4–7. Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E5,8, as well as the susceptibility of these animals to SARS-CoV-29, highlight their importance in potential transmission cycles. While recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described5,10, here we report the emergence of a highly pathogenic FCoV–CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP) originating in Cyprus11. The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears to be very frequent and sequence identities of samples from cats in different districts of the island are strongly supportive of direct transmission. A near-cat-specific deletion in the domain 0 of S is present in more than 90% of cats with FIP. It is unclear as yet whether this deletion is directly associated with disease development, and it may be linked to a biotype switch12. The domain 0 deletion and several amino acid changes in S, particularly the receptor-binding domain, indicate potential changes to receptor binding and cell tropism.

2 June 2023 in Veterinary Record
Verified
Journal Article
Closed access
CACharalampos Attipa
Charalampos Attipa
DGDanielle Gunn‐Moore
Danielle Gunn‐Moore
SMStella Mazeri
Stella Mazeri
DEDemetris Epaminondas
Demetris Epaminondas
MLMaria Lyraki
Maria Lyraki
MGMichaela Gentil
Michaela Gentil

9 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CACharalampos Attipa
Charalampos Attipa
AWAmanda Susan Warr
Amanda Susan Warr
DEDemetris Epaminondas
Demetris Epaminondas
MOMarie O’shea
Marie O’shea
AHAndrew J Hanton
Andrew J Hanton
CTChristine Tait-Burkard
Christine Tait-Burkard
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health 1–3 . Whilst the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed and demonstrated 4–7 . Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E 5,8 , as well as their susceptibility to SARS-CoV-2 9 highlight their importance in potential transmission cycles. Whilst recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described 5,10 , here we report the emergence of a novel, highly pathogenic FCoV-CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP), originating in Cyprus 11 . The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears very frequent and sequence identities of samples from cats in different districts of the island is strongly supportive of direct transmission. A near cat-specific deletion in the domain 0 of S is present in >90% of FIP cats. It is unclear as yet whether this deletion is directly associated with disease development and may be linked to a biotype switch 12 . The domain 0 deletion and several amino acid changes in S, particularly the receptor binding domain, indicate potential changes to receptor binding and cell tropism.

3 October 2024 in Veterinary Research Communications
Verified
Journal Article
Closed access
PDF file
AAAnthi Anatolitou
Anthi Anatolitou
AKA. A. Krystalli
A. A. Krystalli
DEDemetris Epaminondas
Demetris Epaminondas
SPS. K. Papaefthymiou
S. K. Papaefthymiou
KMK. K. Adamama Moraitou
K. K. Adamama Moraitou
NPN. N. Prassinos
N. N. Prassinos

27 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DEDemetris Epaminondas
Demetris Epaminondas
SMStella Mazeri
Stella Mazeri
MLMaria Lyraki
Maria Lyraki
CTChristine Tait-Burkard
Christine Tait-Burkard
Danielle Gunn-MooreDanielle Gunn-Moore
Danielle Gunn-Moore
MFMaria Eleni Filippitzi
Maria Eleni Filippitzi
In 2023, Cyprus experienced a large-scale epizootic of feline infectious peritonitis (FIP) temporally associated with the emergence of a novel feline coronavirus, FCoV-23. While molecular investigations have elucidated the recombinant origin of FCoV-23, field-based clinical and other epidemiological data from FIP cases reported during the epizootic period were needed to better characterize the outbreak. A prospective study was conducted using a structured 31-item questionnaire embedded in veterinary management software to characterize FIP cases diagnosed during the epizootic period (late 2022–2025). Data were voluntarily submitted by registered veterinarians across Cyprus. Cases were included based on a clinical diagnosis of FIP; virological confirmation of FCoV-23 infection was not required for inclusion. Data from 68 FIP cases reported by 22 clinics (response rate 21.0%) were analyzed. Affected cats were older than typically reported for FIP (mean age 3.9 years; median 3.0; range 0.4–12.9 years; SD 3.41). Most cases were documented in Limassol (51.5%) and Nicosia (25.0%). The most frequently reported clinical signs were non-specific like anorexia (60.3%) and weight loss (54.4%), while a variety of neurological and mental manifestations was documented in 35.3% of cases. An albumin-to-globulin ratio <0.8 was observed in 86.8% of tested cats. Antiviral therapy (GS-441524 or molnupiravir) was administered in 92.2% of cases, with reported clinical improvement in 88.9%. These findings demonstrate the value of questionnaire-based surveillance in documenting outbreak-associated FIP patterns. Although individual cases were not uniformly confirmed as FCoV-23 infections, the increased proportion of neurological presentations among FIP cases reported during the epizootic period supports previous molecular evidence suggesting that neurological involvement was associated with FCoV-23 circulation.

6 May 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
DEDemetris Epaminondas
Demetris Epaminondas
SMStella Mazeri
Stella Mazeri
MLMaria Lyraki
Maria Lyraki
CTChristine Tait-Burkard
Christine Tait-Burkard
Danielle Gunn-MooreDanielle Gunn-Moore
Danielle Gunn-Moore
MFMaria Eleni Filippitzi
Maria Eleni Filippitzi
In 2023, Cyprus experienced a large-scale epizootic of feline infectious peritonitis (FIP) temporally associated with the emergence of a novel feline coronavirus, FCoV-23. While molecular investigations have elucidated the recombinant origin of FCoV-23, field-based clinical and other epidemiological data from FIP cases reported during the epizootic period were needed to characterize the outbreak better. A prospective study was conducted using a structured 31-item questionnaire embedded in veterinary management software to characterize FIP cases diagnosed during the epizootic period (late 2022–2025). Data were voluntarily submitted by registered veterinarians across Cyprus. Cases were included based on a clinical diagnosis of FIP; virological confirmation of FCoV-23 infection was not required for inclusion. Data from 68 FIP cases reported by 22 clinics (response rate 21.0%) were analyzed. Affected cats were older than typically reported for FIP (mean age 3.9 years; median 3.0; range 0.4–12.9 years; SD 3.41). Most cases were documented in Limassol (51.5%) and Nicosia (25.0%). The most frequently reported clinical signs were non-specific, like anorexia (60.3%) and weight loss (54.4%), while a variety of neurological and mental manifestations were documented in 35.3% of cases. An albumin-to-globulin ratio < 0.8 was observed in 86.8% of tested cats. Antiviral therapy (GS-441524 or molnupiravir) was administered in 92.2% of cases, with reported clinical improvement of 88.9%. These findings demonstrate the value of questionnaire-based surveillance in documenting outbreak-associated FIP patterns. Although individual cases were not uniformly confirmed as FCoV-23 infections, the increased proportion of neurological presentations among FIP cases reported during the epizootic period supports previous molecular evidence suggesting that neurological involvement was associated with FCoV-23 circulation.